Cerebral Therapeutics Announces Enrollment of First Patient in a Multicenter Randomized Controlled Phase 2b Trial in Epilepsy Read more
Gene Therapy for Blood Disorders: BioMarin Insights, FDA & EMA Guidelines, Demonstrating Durability and More Read more
Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19 (mRNA-1273) if Approved for Use Read more
Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators Read more
Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin Read more
Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1 Read more
Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases Read more
Olema Oncology Announces Clinical Trial Agreement to Evaluate OP-1250 in Combination with Palbociclib (IBRANCE) in Advanced Metastatic Breast Cancer Read more